Current Research Studies
Cancer – PNOC 005: A Phase 1 Study of Modified Measles Virus (Mv-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT)
What is the goal of this study?
The goal of this study is to assess the safety of the phase 2 dose of the modified measles virus (MV-NIS) for patients with recurrent medulloblastoma or ATRT.
Who can join the study?
This study may be a good fit for children and young adults who:
- Are 12 months to 39 years old
- Have recurrent medulloblastoma or ATRT
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.